ERBB2 and mucinous ovarian cancer: ERBB2 (human epidermal growth factor receptor 2, HER2) gene amplification has been reported in approximately 20–30% of invasive mucinous ovarian cancers and 6% of mucinous borderline ovarian carcinomas [47,48,49].